Researchers evaluated data on more than 100,000 participants with osteoporosis from clinical trials of bisphosphonates to determine whether the agents reduced overall mortality.
Researchers evaluated data on more than 100,000 participants with osteoporosis from clinical trials of bisphosphonates to determine whether the agents reduced overall mortality.
New evidence sheds light on the risk of postoperative bone loss among pre- and post-menopausal women with a BRCA mutation who undergo bilateral salpingo-oophorectomy, as well as the potential role of...
An advisory panel to the FDA has recommended the approval of a new treatment option for use in postmenopausal women with osteoporosis and high fracture risk.
An advisory panel to the FDA has recommended the approval of a new treatment option for use in postmenopausal women with osteoporosis and high fracture risk.
Researchers prospectively evaluated bone data of more than 200 breast cancer survivors and more than 500 cancer-free women to compare osteopenia and osteoporosis incidence.
A coalition of more than 40 US and international bone health experts, health care professional organizations, and patient advocacy organizations have released their recommendations for the treatment of...
